Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active Drug Surveillance Program of Ferriprox Use

NCT01838291 is registered in ClinicalTrials.gov with ApoPharma as lead sponsor.

NCT NCT01838291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01838291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active Drug Surveillance Program of Ferriprox Use
Lead sponsor
ApoPharma
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
April 30, 2013
Enrollment
294 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

transfusional iron overload